INVO Fertility Expands Midwest Footprint with $760K Family Beginnings Acquisition
Event summary
- INVO Fertility closed its acquisition of Indiana-based Family Beginnings for $760K in cash and preferred stock.
- Family Beginnings generated $1M in revenue and $0.2M in net income for the 9 months ended September 30, 2025.
- The clinic will retain its existing medical leadership under a multi-year agreement with Dr. James Donahue.
- The acquisition expands INVO's network to four operational fertility clinics in the U.S.
- Family Beginnings was an early adopter of INVO's INVOcell intravaginal culture solution.
The big picture
This acquisition aligns with INVO's strategy of expanding its clinic network through targeted acquisitions, particularly in underserved geographic markets. The deal represents INVO's continued focus on integrating clinics that have already adopted its proprietary INVOcell technology, suggesting a potential pipeline of similar acquisitions. The Midwest expansion comes as INVO positions itself for growth through both organic initiatives and strategic acquisitions, following a period of strong fundamental performance.
What we're watching
- Integration Challenges
- How INVO will maintain Family Beginnings' patient-first approach while integrating operational systems.
- Growth Strategy
- Whether INVO can sustain its clinic acquisition pace while maintaining profitability.
- Technology Adoption
- The pace at which INVOcell adoption grows among acquired clinics and third-party providers.
Related topics